Rosuvastatin, Atorvastatin Have Comparable Efficacy for CAD

THURSDAY, Oct. 19, 2023 -- Rosuvastatin and atorvastatin have comparable efficacy for a composite outcome in adults with coronary artery disease, according to a study published online Oct. 18 in The BMJ. Yong-Joon Lee, M.D., from the Yonsei...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news